NHS NEL
Demonstration Formulary
Demonstration Formulary
2 Cardiovascular system
02-08 Anticoagulants and protamine
Links
NICE CG107: Hypertension in pregnancy: diagnosis and management- NICE CG108: Chronic heart failure in adults: management
- NICE CG126: Stable angina: management
- NICE CG127: Hypertension in adults: diagnosis and management
- NICE CG180: Atrial fibrillation: management
- NICE CG68: Stroke and transient ischaemic attack in over 16s: diagnosis and initial management
- NICE NG185; Acute coronary syndromes
- NICE Patient Decision Aid: Atrial Fibrillation: medicines to help reduce your risk of a stroke - what are the options?
- NICE Patient Decision Aid: Atrial Fibrillation: medicines to help reduce your risk of a stroke - what are the options?
- NICE Patient Decision Aid: Atrial Fibrillation: medicines to help reduce your risk of a stroke - what are the options?
- NICE Patient Decision Aid: Atrial Fibrillation: medicines to help reduce your risk of a stroke - what are the options?
- NICE TA157: Dabigatran etexilate for the prevention of venous thromboembolism after hip or knee replacement surgery in adults
- NICE TA170: Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults
- NICE TA245: Apixaban for the prevention of venous thromboembolism after total hip or knee replacement in adults
- NICE TA249: Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation
- NICE TA256: Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation
- NICE TA261: Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism
- NICE TA275: Stroke and systemic embolism (prevention, non-valvular atrial fibrillation)
- NICE TA287: Rivaroxaban for treating pulmonary embolism and preventing recurrent venous thromboembolism
- NICE TA327: Dabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism
- NICE TA335: Rivaroxaban for preventing adverse outcomes after acute management of acute coronary syndrome (March 2015)
- NICE TA341: Apixaban for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism
- NICE TA354: Edoxaban for treating and for preventing deep vein thrombosis and pulmonary embolism
- NICE TA355: Edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation
- NICE TA607: Rivaroxaban for preventing atherothrombotic events in people with coronary or peripheral artery disease
- UKMI Q&A: Is there an interaction between warfain and proton pump inhibitors?